Janet Folkes and other top hot air balloonists are made "Freeman of the City of London" at a ceremon...
Death (PHIL 176) In this lecture, Professor Kagan invites students to pose the question of how one s...
Death (PHIL 176) In this lecture, Professor Kagan invites students to pose the question of how one s...
EE 290F Synchrotron Radiation for Materials Science Applications (Sp 07) Lecture 26 - X-Ray Microtom...
Riding two abreast with my friend, the traffic past us increaces and we cause a van to narrowly miss...
PubMed |
(0) (0 Votes)
|
Views: (1041) Date: (13-03-09) Pages: () |
Abstract: Cefodizime given once daily for the treatment of upper urinary tract infections and complicated lower urinary tract infections. Hofstet ter AG. Urologische Klinik, Klinikum Grosshadern, Ludwig-Maximilians-U niversit?t, M?nchen. The efficacy of cefodizime (CDZ) in upper urinary tract infections (UUTI) and complicated lower urinary tract infections (LUTI) was assessed by analysis of the combined results of five clinical trials. Doses of CDZ 1 g i.m. daily, 1 x 2 g i.v. or i.m. and 2 x 2 g i.v. were investigated; comparative agents were cefuroxime 3 x 1.5 g and ceftizoxime 1 x 2 g. Median duration of treatment was seven days. A total of 544 patients, 61% of whom had UUTI, entered the studies. Four hundred twenty-two patients were evaluable clinically and 375 bacteriologically. The most frequent pathogen at baseline was Escherichia coli, followed by Proteus mirabilis, Klebsiella spp. and Staphylococcus aureus. Both clinical and bacteriological cure rates were above 90% in all study groups. The dosage of 1 x 2 g CDZ is recommended for the treatment of UUTI and complicated LUTI. PMID: 1526670 [PubMed - indexed for MEDLINE]